AI-Based Virtual Screening of NLRP3 Inflammasome-Targeting Drug Candidates for Alzheimer’s Disease and Evaluation of Blood–Brain Barrier Permeability. EMSGH 2026, 3, 38-47. https://doi.org/10.70267/emsgh.v3.3847.